RJMPDRN REC is a vegan-certified recombinant PDRN produced through a patented biological synthesis platform using engineered ...
Antibodies are the number one immune cells that fight against infection and diseases. However, beyond their natural usage, biochemistry has devised several ways in which these antibodies can be ...
The DNA synthesis market offers significant growth opportunities driven by tailored therapies, DNA-based research, and diagnostics. Key market prospects include advancements in enzymatic synthesis, ...
The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...
On February 20, 2026, in REGENXBIO Inc. et al. v. Sarepta Therapeutics Inc., et al., No. 2024-1408, the Federal Circuit reversed a district court decision which held that claims covering a cultured ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results